Advertisement

Topics

Search Results for "Avesthagen Limited Cosmosid"

01:30 EST 11th February 2016 | BioPortfolio

Matching Channels

None

Matching News

CosmosID closes $6mm Series B

Genomics firm CosmosID Inc. raised $6mm in its Series B financing led by the Applied Value Group.

CosmosID nets $6M for in silico, pan-microbial diagnostic

CosmosID’s powerful diagnostic platform can identify some 20,000 microbes, based on an intricate understanding of microbial biomarkers.

CosmosID completes venture financing

CosmosID Raises $6 Million in Series B Funding

ROCKVILLE, Md., Jan. 27, 2016 /PRNewswire/ -- CosmosID, the leading genomic big data company focused on microbiome research, outbreak investigations, and infectious disease diagnostics, using next-gen...

CosmosID Announces Partnership with QIAGEN for Microbial Analysis

ROCKVILLE, Md., Feb. 3, 2016 /PRNewswire/ -- CosmosID, a leading genomic big data company, today announced a partnership with QIAGEN to launch its metagenomics analysis platform in QIAGEN's CLC Genomi...

Researchers study strains of flesh-eating bacteria to beat toxins

Researchers at the University of Texas Medical Branch at Galveston have discovered strains of flesh-eating bacteria that could lead them to understand how toxins in the bacteria work. This c...

New Agreements Underscore QIAGEN's Leadership in Bioinformatics

HILDEN, Germany and AARHUS, Denmark, February 2, 2016 /PRNewswire/ -- FDA centers and researchers gain access to QIAGEN's enhanced solutions for applications including microbial and microbiome analys...

CTD Holdings Names Dr. Rita Colwell and Dr. Sharon Hrynkow Co-Chairs of Scientific Advisory Board

ALACHUA, FL--(Marketwired - October 26, 2015) - CTD Holdings, Inc. (OTCQB: CTDH) today announced Dr. Rita Colwell, Distinguished University Professor, University of Maryland at College Park and Johns ...

Matching PubMed Articles

None

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement